Quinn JF - Search Results

1

Bowman GL, Shannon J, Frei B, Kaye JA, Quinn JF. Bowman GL, et al. Among authors: quinn jf. J Alzheimers Dis. 2010;19(4):1331-6. doi: 10.3233/JAD-2010-1330. J Alzheimers Dis. 2010. PMID: 20061611 Free PMC article.

2

Mouse cerebral prostaglandins, but not oxidative damage, change with age and are responsive to indomethacin treatment.

Montine KS, Montine TJ, Morrow JD, Frei B, Milatovic D, Eckenstein F, Quinn JF. Montine KS, et al. Among authors: quinn jf. Brain Res. 2002 Mar 15;930(1-2):75-82. doi: 10.1016/s0006-8993(01)03409-6. Brain Res. 2002. PMID: 11879798

3

Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease.

Montine TJ, Quinn JF, Milatovic D, Silbert LC, Dang T, Sanchez S, Terry E, Roberts LJ 2nd, Kaye JA, Morrow JD. Montine TJ, et al. Among authors: quinn jf. Ann Neurol. 2002 Aug;52(2):175-9. doi: 10.1002/ana.10272. Ann Neurol. 2002. PMID: 12210787

4

Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment.

Stackman RW, Eckenstein F, Frei B, Kulhanek D, Nowlin J, Quinn JF. Stackman RW, et al. Among authors: quinn jf. Exp Neurol. 2003 Nov;184(1):510-20. doi: 10.1016/s0014-4886(03)00399-6. Exp Neurol. 2003. PMID: 14637120

5

Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease.

Quinn JF, Montine KS, Moore M, Morrow JD, Kaye JA, Montine TJ. Quinn JF, et al. J Alzheimers Dis. 2004 Feb;6(1):93-7. doi: 10.3233/jad-2004-6110. J Alzheimers Dis. 2004. PMID: 15004331

6

Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease.

Adair JC, Charlie J, Dencoff JE, Kaye JA, Quinn JF, Camicioli RM, Stetler-Stevenson WG, Rosenberg GA. Adair JC, et al. Among authors: quinn jf. Stroke. 2004 Jun;35(6):e159-62. doi: 10.1161/01.STR.0000127420.10990.76. Epub 2004 Apr 22. Stroke. 2004. PMID: 15105518

7

Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.

Vuletic S, Peskind ER, Marcovina SM, Quinn JF, Cheung MC, Kennedy H, Kaye JA, Jin LW, Albers JJ. Vuletic S, et al. Among authors: quinn jf. J Neurosci Res. 2005 May 1;80(3):406-13. doi: 10.1002/jnr.20458. J Neurosci Res. 2005. PMID: 15795933

8

Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease.

Zhang J, Goodlett DR, Quinn JF, Peskind E, Kaye JA, Zhou Y, Pan C, Yi E, Eng J, Wang Q, Aebersold RH, Montine TJ. Zhang J, et al. Among authors: quinn jf. J Alzheimers Dis. 2005 Apr;7(2):125-33; discussion 173-80. doi: 10.3233/jad-2005-7205. J Alzheimers Dis. 2005. PMID: 15851850

9

Safety and acceptability of the research lumbar puncture.

Peskind ER, Riekse R, Quinn JF, Kaye J, Clark CM, Farlow MR, Decarli C, Chabal C, Vavrek D, Raskind MA, Galasko D. Peskind ER, et al. Among authors: quinn jf. Alzheimer Dis Assoc Disord. 2005 Oct-Dec;19(4):220-5. doi: 10.1097/01.wad.0000194014.43575.fd. Alzheimer Dis Assoc Disord. 2005. PMID: 16327349 Clinical Trial.

10

Quantitative in vivo biomarkers of oxidative damage and their application to the diagnosis and management of Alzheimer's disease.

Montine TJ, Quinn JF, Montine KS, Kaye JA, Breitner JC. Montine TJ, et al. Among authors: quinn jf. J Alzheimers Dis. 2005 Mar;8(4):359-67. doi: 10.3233/jad-2005-8405. J Alzheimers Dis. 2005. PMID: 16556967 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

402 results

Search Page

Filters